Combined autologous CD30.CAR‐T cells and nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma after failure of frontline therapy (ACTION study)

Saved in:
Bibliographic Details
Published inHematological oncology Vol. 41; no. S2; pp. 524 - 525
Main Authors Ahmed, S., Mei, M., Kurtz, D. M., Beitinjaneh, A., Grover, N. S., Ramos, C. A., Chabon, J. J., Schultz, A., Ding, C., Myo, A., Alizadeh, A. A., Horak, I. D., Heslop, H. E.
Format Journal Article
LanguageEnglish
Published Chichester Wiley Subscription Services, Inc 01.06.2023
Subjects
CD30 antigen
Hodgkin's lymphoma
Lymphocytes
Lymphocytes T
Lymphoma
Online AccessGet full text

Cover

More Information
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.3164_388